2-Hexylidene cyclopentanone
Common Name: |
2-Hexylidene cyclopentanone |
IUPAC Name: |
2-hexylidenecyclopentan-1-one |
Molecular Formula: |
C7H14OS |
SMILES: |
CCCCCC=C1CCCC1=O |
Inchi: |
1S/C11H18O/c1-2-3-4-5-7-10-8-6-9-11(10)12/h7H,2-6,8-9H2,1H3 |
Inchi Key: |
WZPGQHVPSKTELT-UHFFFAOYSA-N |
Cas No: |
17373-89-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
146.25 |
Mass (g/mol) |
166.136 |
Molar Refractivity |
43.59 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
3 |
Rings |
1 |
TPSA |
42.37 |
Hetero Atoms |
1 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
240.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.013 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.86 |
LogP |
3.246 |
iLOGP |
1.89 |
XLOGP3 |
1.15 |
WLOGP |
2.11 |
MLOGP |
1.74 |
ESOL Log S |
-1.27 |
ESOL Solubility (mg/ml) |
7.8 |
ESOL Solubility (mol/l) |
0.053 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.63 |
Ali Solubility (mg/ml) |
3.39 |
Ali Solubility (mol/l) |
0.02 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.92 |
Silicos-IT Solubility (mg/ml) |
1.76 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.38 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.673 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.627 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |